Absorption of digoxin in man. 1947

L W HANLON, and H GOLD

UI MeSH Term Description Entries
D008297 Male Males
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L W HANLON, and H GOLD
February 1977, The American journal of cardiology,
L W HANLON, and H GOLD
October 1972, Clinical science,
L W HANLON, and H GOLD
December 1975, European journal of clinical pharmacology,
L W HANLON, and H GOLD
January 1972, The New England journal of medicine,
L W HANLON, and H GOLD
May 1978, European journal of clinical pharmacology,
L W HANLON, and H GOLD
October 1975, European journal of clinical pharmacology,
L W HANLON, and H GOLD
January 1981, Arzneimittel-Forschung,
L W HANLON, and H GOLD
February 1972, Deutsche medizinische Wochenschrift (1946),
L W HANLON, and H GOLD
January 1984, European journal of clinical pharmacology,
L W HANLON, and H GOLD
February 1979, International journal of clinical pharmacology and biopharmacy,
Copied contents to your clipboard!